Resveratrol

peroxisome proliferator activated receptor gamma ; Homo sapiens







37 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32954977 Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer. 2022 Feb 3
2 34207527 Endocrine Disrupting Chemicals, Hormone Receptors, and Acne Vulgaris: A Connecting Hypothesis. 2021 Jun 9 1
3 34827205 Quantitative Analysis of Factors Regulating Angiogenesis for Stem Cell Therapy. 2021 Nov 20 1
4 32267731 Resveratrol restores intracellular transport in cystic fibrosis epithelial cells. 2020 Jun 1 2
5 32816149 Exploring conformational changes of PPAR-Ɣ complexed with novel kaempferol, quercetin, and resveratrol derivatives to understand binding mode assessment: a small-molecule checkmate to cancer therapy. 2020 Aug 20 2
6 30674874 PPARα and PPARγ activation attenuates total free fatty acid and triglyceride accumulation in macrophages via the inhibition of Fatp1 expression. 2019 Jan 15 2
7 30920877 The Role of Dietary Phytoestrogens and the Nuclear Receptor PPARγ in Adipogenesis: An in Vitro Study. 2019 Mar 3
8 31185146 The impact of resveratrol on toxicity and related complications of advanced glycation end products: A systematic review. 2019 Sep 1
9 31486447 The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. 2019 Sep 1 2
10 30272285 LncRNA SRA deregulation contributes to the development of atherosclerosis by causing dysfunction of endothelial cells through repressing the expression of adipose triglyceride lipase. 2018 Dec 1
11 28580300 Resveratrol attenuates triglyceride accumulation associated with upregulation of Sirt1 and lipoprotein lipase in 3T3-L1 adipocytes. 2017 Sep 2
12 28953910 Potential miRNA involvement in the anti-adipogenic effect of resveratrol and its metabolites. 2017 1
13 27073428 Hepatoprotective effect of resveratrol against ethanol-induced oxidative stress through induction of superoxide dismutase in vivo and in vitro. 2016 Apr 1
14 27818126 Anti-inflammatory protection afforded by cyanidin-3-glucoside and resveratrol in human intestinal cells via Nrf2 and PPAR-γ: Comparison with 5-aminosalicylic acid. 2016 Dec 25 2
15 27840978 Resveratrol prevents endothelial progenitor cells from senescence and reduces the oxidative reaction via PPAR‑γ/HO‑1 pathways. 2016 Dec 1
16 25030245 Physiologically achievable doses of resveratrol enhance 3T3-L1 adipocyte differentiation. 2015 Jun 1
17 25672876 Resveratrol exerts growth inhibitory effects on human SZ95 sebocytes through the inactivation of the PI3-K/Akt pathway. 2015 Apr 2
18 25833683 Resveratrol Regulates the Quiescence-Like Induction of Activated Stellate Cells by Modulating the PPARγ/SIRT1 Ratio. 2015 Oct 3
19 24584901 Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins. 2014 May 3
20 24796862 Resveratrol and its metabolites bind to PPARs. 2014 May 26 13
21 24975132 A role for peroxisome proliferator-activated receptor gamma in resveratrol-induced colon cancer cell apoptosis. 2014 Sep 7
22 25083916 Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. 2014 Nov 1 1
23 23041272 Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPARγ and adenosine. 2013 Jan 5 2
24 23525482 Mechanisms of resveratrol-induced inhibition of clonal expansion and terminal adipogenic differentiation in 3T3-L1 preadipocytes. 2013 Nov 3
25 22539994 Resveratrol mediated modulation of Sirt-1/Runx2 promotes osteogenic differentiation of mesenchymal stem cells: potential role of Runx2 deacetylation. 2012 4
26 22659145 Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model. 2012 Jul 1
27 22945685 Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes. 2012 Oct 2
28 20372816 Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation. 2010 May 3
29 20534756 Resveratrol, a red wine constituent, blocks the antimitogenic effects of estradiol on human female coronary artery smooth muscle cells. 2010 Sep 1
30 20943792 Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. 2010 Dec 4
31 21113404 Peroxisome Proliferator-Activated Receptor -β/δ, -γ Agonists and Resveratrol Modulate Hypoxia Induced Changes in Nuclear Receptor Activators of Muscle Oxidative Metabolism. 2010 1
32 18728353 Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. 2009 1
33 18776171 Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol. 2009 Feb 5
34 18555852 Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol. 2008 Jul 8
35 17055343 Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma. 2007 Feb 5
36 16849586 Peroxisome proliferator-activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism. 2006 Jul 15 4
37 17007354 [Resveratrol inhibits expression of EMMPRIN from macrophages]. 2006 Jul 3